Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00927030 · ClinicalTrials.gov registry record · Phase 1
Melatonin for Sleep in Children With Autism
A Phase 1 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT00927030 is a Phase 1 study that has completed, run by Vanderbilt University. The registered enrollment target is 17 participants.
The verdict
NCT00927030, a Phase 1 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if liquid supplemental melatonin is an effective treatment for children with autism who have sleep problems related to insomnia (difficulty falling asleep).
Interventions
- DRUG supplemental liquid melatonin
- DRUG flavored liquid or liquid supplemental melatonin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2008-01 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00927030
The ClinicalTrials.gov registry entry for NCT00927030 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which supplemental liquid melatonin is the first listed.
NCT00927030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00927030 about?
NCT00927030 is a clinical study titled "Melatonin for Sleep in Children With Autism". The purpose of this study is to determine if liquid supplemental melatonin is an effective treatment for children with autism who have sleep problems related to insomnia (difficulty falling asleep).
What is the current status of trial NCT00927030?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2008-01. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00927030?
The interventions under investigation include: supplemental liquid melatonin (DRUG), flavored liquid or liquid supplemental melatonin (DRUG).
Who is sponsoring clinical trial NCT00927030?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.